SFG
MYGN icon

Steward Financial Group’s Myriad Genetics MYGN Stock Holding History

Steward Financial Group’s Portfolio MYGN Stock Details MYGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		$0 Buy
+10
New +$190 ﹤0.01% 1471
2023
Q2 		– Sell
-43
Closed – – 795
2023
Q1 		$0 Buy
43
+24
+126% +$487 ﹤0.01% 843
2022
Q4 		$0 Buy
+19
New +$354 ﹤0.01% 718

Other funds holding MYGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Steward Financial Group's MYGN Position: Q3 2023 in Review

Steward Financial Group opened a new position in Myriad Genetics (MYGN) in Q3 2023: 10 shares worth $0. The stake represents ﹤0.01% of the portfolio and ranks #1471 among its holdings. This is a return to the name: Steward Financial Group previously reported a position in MYGN as recently as Q1 2023.

Steward Financial Group first reported a position in MYGN in Q4 2022 and has held it in 3 quarters since. 186 funds tracked by Wall St. Rank hold MYGN as of Q3 2023.

  • Steward Financial Group held 10 shares of Myriad Genetics worth $0 as of Q3 2023.
  • Myriad Genetics was a new Steward Financial Group position in Q3 2023.
  • Myriad Genetics made up ﹤0.01% of Steward Financial Group's portfolio in Q3 2023, its #1471 holding.
  • Steward Financial Group first reported a position in Myriad Genetics in Q4 2022 and has held it in 3 quarters since.
  • 186 funds tracked by Wall St. Rank held Myriad Genetics as of Q3 2023.

Based on Steward Financial Group's 13F filing for Q3 2023, filed 23 Oct 2023.